PROGNOSTIC SIGNIFICANCE OF ELF TEST COMPARED TO LIVER BIOPSY IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

被引：0

作者：

Liguori, Antonio ^{[1
]}

D'Ambrosio, Francesca ^{[1
]}

Viceconti, Nicholas ^{[1
]}

Termite, Fabrizio ^{[1
]}

Petrucci, Lucrezia ^{[1
]}

Galletti, Simone ^{[1
]}

Cardinali, Sara ^{[1
]}

Riccardi, Laura ^{[1
]}

Pizzolante, Fabrizio ^{[1
]}

De Matthaeis, Nicoletta ^{[1
]}

Zocco, Maria Assunta ^{[1
]}

Giustiniani, Maria Cristina ^{[1
]}

Marrone, Giuseppe ^{[1
]}

Biolato, Marco ^{[1
]}

Rapaccini, Gian Ludovico ^{[1
]}

Pompili, Maurizio ^{[1
]}

Grieco, Antonio ^{[1
]}

Urbani, Andrea ^{[1
]}

Sanguinetti, Maurizio ^{[1
]}

Gasbarrini, Antonio ^{[1
]}

Miele, Luca ^{[1
]}

机构：

[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Rome, Italy

来源：

HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

874

引用

页码：S662 / S662

页数：1

共 50 条

[21] Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Zazueta, Alejandra
Valenzuela-Perez, Lucia
Ortiz-Lopez, Nicolas
Pinto-Leon, Araceli
Torres, Veronica
Guinez, Danette
Aliaga, Nicolas
Merino, Pablo
Sandoval, Alexandra
Covarrubias, Natalia
Perez de Arce, Edith
Cattaneo, Maximo
Urzua, Alvaro
Roblero, Juan Pablo
Poniachik, Jaime
Gotteland, Martin
Magne, Fabien
Beltran, Caroll Jenny
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
[22] Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
Nakamura, Toru
Masuda, Atsutaka
Nakano, Dan
Amano, Keisuke
Sano, Tomoya
Nakano, Masahito
Kawaguchi, Takumi
CELLS, 2025, 14 (06)
[23] Subclinical myocardial fibrosis is related to disease severity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Nabilou, Puria
Wiese, Signe
Hetland, Liv
Werge, Mikkel
Thing, Mira
Rashu, Elias
Junker, Anders
Barlose, Mads
Siebner, Hartwig
Moller, Soren
Bendtsen, Flemming
Gluud, Lise Lotte
Hove, Jens
JOURNAL OF HEPATOLOGY, 2024, 80 : S555 - S555
[24] Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Ramanathan, Raghu
Patwa, Sohum A.
Ali, Ahmad Hassan
Ibdah, Jamal A.
CELLS, 2023, 12 (24)
[25] Metabolic dysfunction-associated steatotic liver disease and the heart
Driessen, Stan
Francque, Sven M.
Anker, Stefan D.
Cabezas, Manuel Castro
Grobbee, Diederick E.
Tushuizen, Maarten E.
Holleboom, Adriaan G.
HEPATOLOGY, 2023,
[26] Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italian women: is liver fibrosis independent from menopause?
Chen, R.
Salamone, A.
Abbati, C.
Capelli, R.
Santangeli, E.
Stefanini, B.
Indre, M. G.
Ravaioli, F.
Piscaglia, F.
Ferri, S.
DIGESTIVE AND LIVER DISEASE, 2025, 57
[27] Metabolic dysfunction-associated steatotic liver disease in adults
不详
NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):
[28] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
Castillo-Nunez, Yulino
Almeda-Valdes, Paloma
Gonzalez-Galvez, Guillermo
Arechavaleta-Granell, Maria del Rosario
CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166
[29] Metabolic dysfunction-associated steatotic liver disease in adults
Huang, Daniel Q.
Wong, Vincent W. S.
Rinella, Mary E.
Boursier, Jerome
Lazarus, Jeffrey V.
Yki-Jarvinen, Hannele
Loomba, Rohit
NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):
[30] Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
Orfanidou, Myrsini
Polyzos, Stergios A.
MEDICINA-LITHUANIA, 2025, 61 (01):

← 1 2 3 4 5 →